182 related articles for article (PubMed ID: 20684745)
1. Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.
Ballard C; Creese B; Corbett A; Aarsland D
Expert Opin Drug Saf; 2011 Jan; 10(1):35-43. PubMed ID: 20684745
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
3. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
Ballard C; Hanney ML; Theodoulou M; Douglas S; McShane R; Kossakowski K; Gill R; Juszczak E; Yu LM; Jacoby R;
Lancet Neurol; 2009 Feb; 8(2):151-7. PubMed ID: 19138567
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
5. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
Ballard C; Corbett A; Chitramohan R; Aarsland D
Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
[TBL] [Abstract][Full Text] [Related]
6. Current issues in dementia pharmacotherapy.
Daiello LA
Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
8. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic drugs in dementia: benefits and harm.
Ballard C; Howard R
Nat Rev Neurosci; 2006 Jun; 7(6):492-500. PubMed ID: 16715057
[TBL] [Abstract][Full Text] [Related]
10. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
Gareri P; De Fazio P; Manfredi VG; De Sarro G
J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
[TBL] [Abstract][Full Text] [Related]
11. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
12. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia.
Carson S; McDonagh MS; Peterson K
J Am Geriatr Soc; 2006 Feb; 54(2):354-61. PubMed ID: 16460391
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dementia: anything new?
Machado JC; Caramelli P
Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes.
Burke AD; Tariot PN
Expert Opin Pharmacother; 2009 Oct; 10(15):2407-14. PubMed ID: 19663744
[TBL] [Abstract][Full Text] [Related]
17. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Ballard CG; Margallo-Lana ML
J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
Lawlor BA
J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
Haw C; Stubbs J; Yorston G
Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
[TBL] [Abstract][Full Text] [Related]
20. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.
Greenblatt HK; Greenblatt DJ
J Clin Pharmacol; 2016 Sep; 56(9):1048-57. PubMed ID: 26953213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
